AllianceBernstein
VANI icon

AllianceBernstein’s Vivani Medical VANI Stock Holding History

AllianceBernstein’s Portfolio VANI Stock Details VANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,275
Closed -$37K – 3182
2017
Q1 		$37K Hold
1,275
– – ﹤0.01% 2975
2016
Q4 		$60K Hold
1,275
– – ﹤0.01% 2986
2016
Q3 		$108K Sell
1,275
-138
-10% -$12.2K ﹤0.01% 2926
2016
Q2 		$121K Buy
1,413
+238
+20% +$24.8K ﹤0.01% 2891
2016
Q1 		$136K Sell
1,175
-188
-14% -$21.6K ﹤0.01% 2782
2015
Q4 		$193K Sell
1,363
-220
-14% -$32.2K ﹤0.01% 2755
2015
Q3 		$225K Buy
1,583
+187
+13% +$51.9K ﹤0.01% 2740
2015
Q2 		$456K Buy
1,396
+221
+19% +$70.9K ﹤0.01% 2618
2015
Q1 		$362K Buy
+1,175
New +$327K ﹤0.01% 2606

Other funds holding VANI

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VDBMI
Van Den Berg Management I Austin, Texas $436M AUM 40.66% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CD
Carl Domino West Palm Beach, Florida $82M AUM 19.36% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

AllianceBernstein's VANI Position: Q2 2017 in Review

AllianceBernstein sold out of Vivani Medical (VANI) in Q2 2017, closing a stake of 1,275 shares — an estimated $37K sold.

AllianceBernstein first reported a position in VANI in Q1 2015 and held it in 9 quarters. The position peaked at $456K in Q2 2015. 44 funds tracked by Wall St. Rank hold VANI as of Q2 2017.

  • AllianceBernstein reported no remaining Vivani Medical position as of Q2 2017 after selling out during the quarter.
  • AllianceBernstein sold 1,275 Vivani Medical shares in Q2 2017, an estimated $37K.
  • AllianceBernstein first reported a position in Vivani Medical in Q1 2015 and held it in 9 quarters.
  • AllianceBernstein's Vivani Medical position peaked at $456K in Q2 2015.
  • 44 funds tracked by Wall St. Rank held Vivani Medical as of Q2 2017.

Based on AllianceBernstein's 13F filing for Q2 2017, filed 10 Aug 2017.